Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (NYSE: EW), Chemed (NYSE: CHE) and Accuray Inc (NASDAQ: ARAY)

By Jason Carr

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Edwards Lifesciences (NYSE: EW), Chemed (NYSE: CHE) and Accuray Inc (NASDAQ: ARAY).

Edwards Lifesciences (NYSE: EW)

In a report released today, Glenn Novarro from RBC Capital reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), with a price target of $120. The company’s shares opened today at $114.60.

According to TipRanks.com, Novarro is a top 100 analyst with an average return of 13.3% and a 83.0% success rate. Novarro covers the Healthcare sector, focusing on stocks such as Integer Holdings Corporation, Boston Scientific Corp, and Varian Medical Systems.

Currently, the analyst consensus on Edwards Lifesciences is Strong Buy and the average price target is $123.25, representing a 7.5% upside.

In a report issued on May 16, Goldman Sachs also initiated coverage with a Buy rating on the stock with a $138 price target.
Chemed (NYSE: CHE)

In a report released today, Frank Morgan from RBC Capital reiterated a Hold rating on Chemed (NYSE: CHE), with a price target of $208. The company’s shares opened today at $202.13, close to its 52-week high of $216.01.

According to TipRanks.com, Morgan is a 5-star analyst with an average return of 12.7% and a 64.0% success rate. Morgan covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care Corp, Quest Diagnostics Inc, and Surgery Partners Inc.

Chemed has an analyst consensus of Moderate Buy, with a price target consensus of $204.

Accuray Inc (NASDAQ: ARAY)

In a report released today, Brandon Henry from RBC Capital reiterated a Hold rating on Accuray Inc (NASDAQ: ARAY), with a price target of $5. The company’s shares opened today at $4.05, close to its 52-week low of $3.85.

According to TipRanks.com, Henry is a 4-star analyst with an average return of 19.2% and a 81.3% success rate. Henry covers the Healthcare sector, focusing on stocks such as Varian Medical Systems, Zimmer Biomet Holdings, and Baxter International.

Accuray Inc has an analyst consensus of Moderate Buy, with a price target consensus of $6.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.